Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • reaffirms

Tag: reaffirms

KeyBanc Raises Alphabet (GOOGL) Price Target to $215, Reaffirms ‘Overweight’
Posted in Business

KeyBanc Raises Alphabet (GOOGL) Price Target to $215, Reaffirms ‘Overweight’

Estimated read time 2 min read
Posted on July 20, 2025
by Joelgalvan

Alphabet Inc. (NASDAQ:GOOGL) is one of the AI Stocks on Wall Street’s Radar. On July 17, KeyBanc analyst Justin Patterson raised…

Learn More Leave a Comment on KeyBanc Raises Alphabet (GOOGL) Price Target to $215, Reaffirms ‘Overweight’
June inflation data reaffirms Fed pause as tariff uncertainty grows
Posted in Business

June inflation data reaffirms Fed pause as tariff uncertainty grows

Estimated read time 4 min read
Posted on July 17, 2025
by Joelgalvan

June’s Consumer Price Index (CPI) report likely gives the Federal Reserve room to continue its wait-and-see approach to cutting rates…

Learn More Leave a Comment on June inflation data reaffirms Fed pause as tariff uncertainty grows
H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results
Posted in Business

H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results

Estimated read time 2 min read
Posted on July 1, 2025
by Joelgalvan

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target…

Learn More Leave a Comment on H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results
UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook
Posted in Business

UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook

Estimated read time 2 min read
Posted on July 1, 2025
by Joelgalvan

Elevance Health, Inc. (NYSE:ELV) ranks among the best fundamental stocks to buy according to hedge funds. On June 17, UBS…

Learn More Leave a Comment on UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook
Ilia Topuria reaffirms welterweight ambitions following historic UFC 317 campaign 
Posted in Sports

Ilia Topuria reaffirms welterweight ambitions following historic UFC 317 campaign 

Estimated read time 3 min read
Posted on June 30, 2025
by Joelgalvan

Ilia Topuria has set his sight on capturing a third title following his historic first-round knockout win over Charles Oliveira…

Learn More Leave a Comment on Ilia Topuria reaffirms welterweight ambitions following historic UFC 317 campaign 
Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating
Posted in Business

Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating

Estimated read time 2 min read
Posted on June 23, 2025
by Joelgalvan

The Home Depot, Inc. (NYSE:HD) is one of the best dividend stocks according to Jim Cramer. TD Cowen reiterated a…

Learn More Leave a Comment on Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating
Fitch Reaffirms The Bank of Nova Scotia (BNS)’s Credit Ratings; Outlook Steady
Posted in Business

Fitch Reaffirms The Bank of Nova Scotia (BNS)’s Credit Ratings; Outlook Steady

Estimated read time 3 min read
Posted on June 14, 2025
by Joelgalvan

The Bank of Nova Scotia (NYSE:BNS) is one of the best Goldman Sachs bank stocks. On June 9, Fitch Ratings…

Learn More Leave a Comment on Fitch Reaffirms The Bank of Nova Scotia (BNS)’s Credit Ratings; Outlook Steady
Benchmark Reaffirms Buy on TAT Technologies (TATT) After Major MRO Deal
Posted in Business

Benchmark Reaffirms Buy on TAT Technologies (TATT) After Major MRO Deal

Estimated read time 2 min read
Posted on May 26, 2025
by Joelgalvan

Benchmark analysts reaffirmed their Buy rating on TAT Technologies Ltd. (NASDAQ:TATT) and maintained a $35 price target on May 23,…

Learn More Leave a Comment on Benchmark Reaffirms Buy on TAT Technologies (TATT) After Major MRO Deal
JMP Reaffirms Market Outperform Rating on Workday After Mixed Q1 Report
Posted in Business

JMP Reaffirms Market Outperform Rating on Workday After Mixed Q1 Report

Estimated read time 2 min read
Posted on May 25, 2025
by Joelgalvan

JMP analysts gave Workday Inc. (NASDAQ:WDAY) a Market Outperform rating on May 23, along with a stable price target of…

Learn More Leave a Comment on JMP Reaffirms Market Outperform Rating on Workday After Mixed Q1 Report
Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal
Posted in Business

Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal

Estimated read time 2 min read
Posted on May 23, 2025
by Joelgalvan

Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on May 20, following the…

Learn More Leave a Comment on Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal

Posts navigation

← Older Articles

Recent Posts

  • England vs India: Zak Crawley books Ashes spot with excellent Old Trafford innings – and reacts to Lord’s needle | Cricket News
  • Schmidt urges Wallabies to rediscover ‘edge’ to send Lions series to decider
  • Analyst Bullish on Reddit (RDDT) Amid a New ‘Phenomenal’ Data Point Despite AI Concerns
  • Chemical Companies Revenue Growth: Chemical companies to post 5-10% revenue growth in Q1 amid tariff concerns, weaker rupee
  • 2 Teams Have Made Trade Offers For Jonathan Kuminga

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.